Genescience Pharmaceuticals Co., Ltd.

1.Manufacturing:
1)Jintropin® (rhGH), dominant player in China and the only officially approved 191 amino acid hGH made by proprietary secretion technology in China.
2)Jintropin® rhGH AQ, dominant player in China and the only officially approved 191 amino acid hGH made by proprietary secretion technology in China.
3)Scimax® (rhG-CSF), leading brand in domestic market.
4)Granmac® (rhGM-CSF).
5)Jintrotide® (Octreotide Acetate for Injection) etc.

2.Contract manufacturing

3.Marketing

4.Distribution

5.Regulatory affairs (IND, NDA, ANDA, biosimilar or follow-on biologics)

6.In-licensing and out-licensing

1.Experienced management team, well educated in U.S.A; Strong R & D center with more than 30 senior professionals including PhDs.

2.The largest biogeneric manufacturing capacities with advanced production facility in China.

3.Solid Marketing Capability: national marketing and sales networks cover major cities and more than 600 large hospitals. A dominant player in domestic market with global branding influence.

4.Strong R&D Pipeline: over 10 products on the way.

1. Locates in Changchun High-Tech Development Zone: more than 20,000m² sq

2. Largest production facility in China for biopharmaceuticals

3. Largest E.coli fermentor in China

4. Finest equipped with mostly imported equipment